Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results
Go back to Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results| (NASDAQ: OCUL) | Delayed: 9.99 -0.15 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.14 | 52 Week High | $14.50 | |||
| Open | $10.15 | 52 Week Low | $4.04 | |||
| Day High | $10.26 | P/E | N/A | |||
| Day Low | $9.90 | EPS | $0.00 | |||
| Volume | 4,100,932 | |||||
